Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

IV IFHNOS Global CME on Head and Neck Cancers /
Mutational drivers of thyroid cancer

1st - 3rd Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.11.16
Views: 1488

Dr Alexsandr Lavrov - N.I.Pirogov Russian National Research Medical University, Moscow, Russia

Dr Lavrov speaks with ecancertv at the IFHNOS 2016 session in Moscow about molecular genetics aiding in diagnosis and treatment of thyroid cancer.

He outlines the processes by which mutational aberrations can be detected, and how to cope with the wealth of data rendered by next-generation sequencing.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation